Award

Canakinumab

NORTHERN HEALTH AND SOCIAL CARE TRUST

This public procurement record has 3 releases in its history.

Award

03 Sep 2025 at 09:22

Award

07 Aug 2025 at 14:26

Award

26 Jun 2025 at 09:32

Summary of the contracting process

The Northern Health and Social Care Trust has entered into a contract for the supply of Canakinumab, a pharmaceutical product, in a procurement process classified under public authority - central government, with applicability under Northern Irish devolved regulations. This procurement process, located in Antrim, Northern Ireland, is complete at the award stage. The contract commenced on 19 August 2025 and is set to run until 31 May 2028, with the supplier identified as NOVARTIS PHARMACEUTICALS UK LIMITED. The procurement method employed was a direct award, justified by the supplier's exclusive intellectual property rights, which precludes competition.

This tender opportunity, while specific in its requirements due to patent constraints, offers robust business growth avenues for large pharmaceutical companies with a substantial focus on innovative drug development. It underscores the importance of holding exclusive rights and patents in the pharmaceutical industry, providing those organisations with monopoly-like conditions for offering specialised products like Canakinumab. Businesses seeking to participate in future tenders of this nature should focus on developing or acquiring exclusive intellectual property rights to remain competitive. Additionally, pharmaceutical companies should anticipate opportunities where exclusivity due to intellectual property rights could be leveraged in direct award scenarios, potentially expanding their market share through strategic patent acquisitions.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Canakinumab

Notice Description

The intended contract is for the supply of Canakinumab to Northern Health and Social Care Trust for up to a maximum of 3 years

Procurement Information

Purchase of drugs which are subject to patent protection/Sole MA Holder, where no reasonable alternative or substitute exists. Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract - (a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0553ef
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/053420-2025
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£120,000 £100K-£500K
Contracts Value
£120,000 £100K-£500K

Notice Dates

Publication Date
3 Sep 20255 months ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
26 Jun 20258 months ago
Contract Period
18 Aug 2025 - 31 May 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NORTHERN HEALTH AND SOCIAL CARE TRUST
Contact Name
Not specified
Contact Email
diane.trimble@northerntrust.hscni.net
Contact Phone
Not specified

Buyer Location

Locality
ANTRIM
Postcode
BT41 2RL
Post Town
Northern Ireland
Country
Northern Ireland

Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN0D Antrim and Newtownabbey
Delivery Location
Not specified

Local Authority
Antrim and Newtownabbey
Electoral Ward
Springfarm
Westminster Constituency
South Antrim

Supplier Information

Number of Suppliers
1
Supplier Name

NOVARTIS PHARMACEUTICALS

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-0553ef-2025-09-03T10:22:17+01:00",
    "date": "2025-09-03T10:22:17+01:00",
    "ocid": "ocds-h6vhtk-0553ef",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PBRP-6676-CQZY",
            "name": "Northern Health And Social Care Trust",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PBRP-6676-CQZY"
            },
            "address": {
                "streetAddress": "Brettan Hall, Antrim Area Hospital, Bush Road",
                "locality": "Antrim",
                "postalCode": "BT41 2RL",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKN0D"
            },
            "contactPoint": {
                "email": "diane.trimble@northerntrust.hscni.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "scheme": "UK_CA_TYPE",
                        "id": "publicAuthorityCentralGovernment",
                        "description": "Public authority - central government"
                    },
                    {
                        "scheme": "UK_CA_DEVOLVED_REGULATIONS",
                        "id": "GB-NIR",
                        "description": "Northern Irish devolved regulations apply"
                    }
                ]
            }
        },
        {
            "id": "GB-COH-00119006",
            "name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
            "identifier": {
                "scheme": "GB-COH",
                "id": "00119006"
            },
            "additionalIdentifiers": [
                {
                    "scheme": "GB-PPON",
                    "id": "PJTX-5182-QVLR"
                }
            ],
            "address": {
                "streetAddress": "2nd Floor, The Westworks Building White City Place",
                "locality": "London",
                "postalCode": "W12 7FQ",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI33"
            },
            "contactPoint": {
                "email": "commercial.pricing@novartis.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "url": "https://www.novartis.com/uk-en/",
                "scale": "large",
                "vcse": false,
                "publicServiceMissionOrganization": false,
                "shelteredWorkshop": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PBRP-6676-CQZY",
        "name": "Northern Health And Social Care Trust"
    },
    "tender": {
        "id": "DAC128/0525PM",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Canakinumab",
        "description": "The intended contract is for the supply of Canakinumab to Northern Health and Social Care Trust for up to a maximum of 3 years",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "Purchase of drugs which are subject to patent protection/Sole MA Holder, where no reasonable alternative or substitute exists. Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract - (a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.",
        "lots": [
            {
                "id": "1",
                "status": "complete"
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            }
        ],
        "riskDetails": "Previous spend on DAC totalling PS99,278. Aggregate value is PS219,278.",
        "procurementMethodRationaleClassifications": [
            {
                "id": "singleSuppliersIntellectualPropertyExclusiveRights"
            }
        ],
        "coveredBy": [
            "GPA"
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Canakinumab",
            "status": "active",
            "value": {
                "amountGross": 144000,
                "amount": 120000,
                "currency": "GBP"
            },
            "mainProcurementCategory": "goods",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-COH-00119006",
                    "name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33600000",
                            "description": "Pharmaceutical products"
                        }
                    ],
                    "deliveryAddresses": [
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2025-08-19T00:00:00+01:00",
                "endDate": "2028-05-31T23:59:59+01:00"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "035302-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/035302-2025",
                    "datePublished": "2025-06-26T10:32:41+01:00",
                    "format": "text/html"
                },
                {
                    "id": "046999-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK6",
                    "description": "Contract award notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/046999-2025",
                    "datePublished": "2025-08-07T15:26:25+01:00",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2025-08-19T23:59:59+01:00",
                    "status": "scheduled"
                }
            ],
            "date": "2025-07-04T00:00:00+01:00",
            "standstillPeriod": {
                "endDate": "2025-08-18T23:59:59+01:00"
            }
        }
    ],
    "language": "en",
    "contracts": [
        {
            "id": "1",
            "awardID": "1",
            "title": "Canakinumab",
            "status": "active",
            "period": {
                "startDate": "2025-08-19T00:00:00+01:00",
                "endDate": "2028-05-31T23:59:59+01:00"
            },
            "value": {
                "amountGross": 144000,
                "amount": 120000,
                "currency": "GBP"
            },
            "aboveThreshold": true,
            "dateSigned": "2025-08-19T00:00:00+01:00",
            "noAgreedMetricsRationale": "Not applicable as contract value is less than PS5 million",
            "documents": [
                {
                    "id": "053420-2025",
                    "documentType": "contractNotice",
                    "noticeType": "UK7",
                    "description": "Contract details notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/053420-2025",
                    "datePublished": "2025-09-03T10:22:17+01:00",
                    "format": "text/html"
                }
            ]
        }
    ]
}